Corcept Therapeutics Incorporated
CORT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $125 | $103 | $90 | $128 |
| Short-Term Investments | $297 | $239 | $233 | $256 |
| Receivables | $74 | $69 | $84 | $58 |
| Inventory | $12 | $12 | $14 | $12 |
| Other Curr. Assets | $11 | $10 | $8 | $8 |
| Total Curr. Assets | $541 | $443 | $439 | $472 |
| Property Plant & Equip (Net) | $7 | $7 | $8 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $103 | $173 | $248 | $220 |
| Tax Assets | $153 | $162 | $144 | $131 |
| Other NC Assets | $20 | $16 | $8 | $10 |
| Total NC Assets | $282 | $359 | $408 | $369 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $824 | $802 | $846 | $841 |
| Liabilities | – | – | – | – |
| Payables | $34 | $24 | $28 | $15 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $14 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $101 | $94 | $78 | $83 |
| Total Curr. Liab. | $172 | $145 | $143 | $141 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $14 | $16 | $14 | $14 |
| Total NC Liab. | $19 | $21 | $20 | $20 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $7 | $7 | $7 |
| Total Liabilities | $192 | $166 | $163 | $161 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $619 | $599 | $564 | $544 |
| AOCI | $2 | $2 | $1 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $632 | $636 | $683 | $680 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $824 | $802 | $846 | $841 |
| Net Debt | -$124 | -$102 | -$89 | -$127 |